Dexcom (DXCM) Income from Continuing Operations (2010 - 2026)

Dexcom (DXCM) has 17 years of Income from Continuing Operations data on file, last reported at 199500000.0 in Q1 2026.

• On a quarterly basis, Income from Continuing Operations rose 89.28% year-over-year to 199500000.0 in Q1 2026; TTM through Mar 2026 was 930400000.0, a 73.84% increase from a year earlier, with the FY2025 full-year figure at 836300000.0, up 45.14% from the prior year.
• Income from Continuing Operations for Q1 2026 stood at 199500000.0, down from 267300000.0 in the prior quarter.
• Over the last five years, Income from Continuing Operations for DXCM reached as high as 283800000.0 in Q3 2025 and fell as low as 48600000.0 in Q1 2023.
• Historically, Income from Continuing Operations has averaged 146747058.82 across 5 years, with a median of 134600000.0 in 2024.
• Across the five-year window, Income from Continuing Operations soared 1832.08% in 2022 and plunged 50.05% in 2023, its largest moves.
• Year by year, Income from Continuing Operations stood at 91800000.0 in 2022, then surged by 179.19% to 256300000.0 in 2023, then tumbled by 40.81% to 151700000.0 in 2024, then jumped by 76.2% to 267300000.0 in 2025, then dropped by 25.36% to 199500000.0 in 2026.
• Per Business Quant data, the three most recent Income from Continuing Operations figures were 199500000.0 in Q1 2026, 267300000.0 in Q4 2025, and 283800000.0 in Q3 2025.